Liberate Bio’s LNP-Mediated In Vivo Programming of Monocytes for Rapid B Cell Depletion in NHPs...

Lipid nanoparticle startup emerges with $31M from Khosla for in vivo cell therapies

Liberate Bio Demonstrates First In Vivo CAR-M–Mediated B-Cell Depletion in Non-Human Primates

Shawn Davis Speaks at PODD Conference, Oct 27-28

Walter Strapps Speaks at Advancing Cell + Gene Therapies for Cancer | ASGCT

Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs

Liberate Bio Announces Expansion of its Leadership Team

Taking an ‘upside-down’ approach to mRNA delivery

Deliver, but not to the liver: Liberate Bio developing targeted nucleic acid delivery technologies

Liberate Bio: Pushing into the Future of Therapeutic Vectors

Liberate Bio is Bringing Precision Delivery to Genetic Medicines